Bayer animal health sale could rake in $8B and bids from private equity: report

Bayer's nailing down the details on its long-anticipated animal health sale, reports say. It's planning an auction, for one thing, and the deal's drawing interest from top private equity and buyout players. And if bidders don't offer up enough for Bayer's taste, it might just spin off the unit instead.